Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 3/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.35 |
| ▸ | PARG | Q86W56 | 6/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.34 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3929676 | 0.92 | CYP2C9 (0.39) | CYP2C9NR1I2PARGHDAC1HDAC6 | |
| SCHEMBL4068112 | 0.91 | CYP2C9 (0.39) | CYP2C9NR1I2PARGHDAC1HDAC6 | |
| SCHEMBL3920862 | 0.90 | CYP2C9 (0.39) | CYP2C9NR1I2PARGHDAC1HDAC6 | |
| SCHEMBL4075666 | 0.89 | CYP2C9 (0.37) | CYP2C9NR1I2PARGHDAC1HDAC6 | |
| SCHEMBL4068258 | 0.87 | CYP2C9 (0.37) | CYP2C9NR1I2PARGHDAC1HDAC6 | |
| SCHEMBL4073002 | 0.87 | CYP2C9 (0.42) | CYP2C9NR1I2PARGHDAC1HDAC6 | |
| SCHEMBL3922950 | 0.87 | CYP2C9 (0.40) | CYP2C9NR1I2HDAC1HDAC6HDAC8 | |
| SCHEMBL4066606 | 0.87 | CYP2C9 (0.39) | CYP2C9NR1I2PARGHDAC1HDAC6 | |
| SCHEMBL3922961 | 0.86 | ERCC5 (0.36) | CYP2C9NR1I2PARGPTGDR2MAPT | |
| SCHEMBL3930411 | 0.86 | PTGDR2 (0.36) | CYP2C9NR1I2PTGS1PTGS2PARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1786807-B1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2009-07-29 | — | — | EP | claimed |